Conference Coverage
Conference Coverage
Two historical events that changed the field of gastroenterology
A gunshot leads to important insights in gastroenterology and years later, ethical dilemmas.
Conference Coverage
Noteworthy advances in treatment and management of IBD
A team of leading GI clinicians describes the most noteworthy achievements in IBD research over the last year.
Latest News
Naltrexone is safe and beneficial in AUD with cirrhosis
VIENNA –
Conference Coverage
Celiac disease: Update on diagnosis and monitoring
The best initial serology test for diagnosis in suspected celiac disease is the tissue transglutaminase IgA antibody.
Conference Coverage
Advances in pancreaticobiliary disease interventions: More options and better outcomes
Evidence-based advances are changing the landscape of pancreaticobiliary disease management.
Conference Coverage
Eosinophilic esophagitis: A year in review
Diet remains the only therapy targeting the cause of EoE and offers a potential drug-free remission.
Conference Coverage
Does private equity ensure survival of GI practices?
Private equity offers the allure of financial and administrative stability.
Conference Coverage
Breakthroughs and challenges in hepatology
“I have witnessed some of the miracles in modern medicine. However, there remain many challenges.’
Conference Coverage
Triple-agonist retatrutide hits new weight loss highs
“I have never seen weight loss at this level” after nearly 1 year of treatment.
Latest News
‘Exciting time for NASH’ with resmetirom phase 3 results
Two doses of resmetirom met the primary endpoints of NASH resolution and no worsening of fibrosis on liver biopsy.